- Home
- NWFL vs ENLV Comparison
NWFL vs ENLV Comparison
Compare NWFL & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NWFL | ENLV |
|---|---|---|
| Founded | 1870 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.8M | 249.3M |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | NWFL | ENLV |
|---|---|---|
| Price | $29.14 | $1.15 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $33.00 | $13.00 |
| AVG Volume (30 Days) | 30.1K | ★ 339.6K |
| Earning Date | 04-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.32% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $7,399,000.00 | N/A |
| Revenue This Year | $34.35 | N/A |
| Revenue Next Year | $5.55 | N/A |
| P/E Ratio | $13.36 | ★ N/A |
| Revenue Growth | ★ 3.69 | N/A |
| 52 Week Low | $21.25 | $0.66 |
| 52 Week High | $32.23 | $2.10 |
Technical Indicators
Market Signals| Indicator | NWFL | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 50.51 |
| Support Level | $27.50 | $1.00 |
| Resistance Level | $29.58 | $1.07 |
| Average True Range (ATR) | 0.78 | 0.07 |
| MACD | -0.26 | -0.02 |
| Stochastic Oscillator | 11.92 | 23.08 |
Price Performance
Historical ComparisonAbout NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.